Table 4.

Treatment-related adverse events (all patients, n=56)

Treatment-related adverse events	All patients (n=56): Number of patients (%)
	All grade	≥Grade 3
Hematologic adverse events
Leukopenia	18 (32.1%)	1 (1.8%)
Neutropenia	27 (48.2%)	9 (16.1%)
Febrile neutropenia	0 (0.0%)	0 (0.0%)
Anemia	24 (42.9%)	0 (0.0%)
Thrombocytopenia	10 (17.9%)	0 (0.0%)
Non-hematologic adverse events
Anorexia	10 (17.9%)	0 (0.0%)
Nausea	15 (26.8%)	4 (7.1%)
Vomiting	8 (14.3%)	4 (7.1%)
Stomatitis	12 (21.4%)	0 (0.0%)
Neuropathy	14 (25.0%)	2 (3.6%)
Diarrhea	12 (21.4%)	1 (1.8%)
Infection	3 (5.4%)	1 (1.8%)
Skin rash	5 (8.9%)	0 (0.0%)
AST/ALT increased	3 (5.4%)	0 (0.0%)